Show simple item record

dc.contributor.authorEdvardsen, Magnus
dc.contributor.authorHansen, Ellen-Sofie
dc.contributor.authorUeland, Thor
dc.contributor.authorAukrust, Pål
dc.contributor.authorBrækkan, Sigrid Kufaas
dc.contributor.authorMorelli, Vania Maris
dc.contributor.authorHansen, John Bjarne
dc.date.accessioned2024-01-19T10:16:55Z
dc.date.available2024-01-19T10:16:55Z
dc.date.issued2023-02-01
dc.description.abstractBackground - von Willebrand factor (VWF) and its cleaving protease, ADAMTS-13, form a pivotal axis that regulates hemostasis. However, the role of the VWF-ADAMTS-13 axis in the risk of future venous thromboembolism (VTE) is unknown.<p> <p>Objectives - To investigate whether plasma ADAMTS-13 levels and an imbalance with VWF levels, assessed as the VWF/ADAMTS-13 ratio, are associated with the risk of future VTE.<p> <p>Patients/Methods - A population-based nested case-control study, comprising 383 incident VTE cases and 780 age- and sex-matched controls, was derived from the Tromsø study cohort (1994-2007). Antigen levels of ADAMTS-13 and VWF were measured in plasma samples obtained at cohort baseline. Odds ratios (ORs) with 95% CIs were estimated according to quartile cutoffs of ADAMTS-13 and VWF/ADAMTS-13 ratio determined in controls.<p> <p>Results - In age- and sex-adjusted analysis, ADAMTS-13 levels were inversely associated with the VTE risk, with an OR of 1.40 (95% CI, 0.99-1.99) for the lowest vs highest quartiles. The VWF/ADAMTS-13 ratio was linearly associated with the VTE risk (P for trend = .001), with an OR of 1.70 (95% CI, 1.19-2.43) for the highest vs lowest quartiles, and the association was particularly pronounced for unprovoked VTE (OR, 2.81; 95% CI, 1.65-4.81). The ORs were only slightly attenuated after additional adjustments for body mass index and C-reactive protein.<p> <p>Conclusions - Lowered ADAMTS-13 levels and an imbalance between ADAMTS-13 and VWF levels, reflected by an increased VWF/ADAMTS-13 ratio, were associated with an increased risk of future VTE. Our findings suggest that the VWF-ADAMTS-13 axis is involved in the pathogenesis of VTE.en_US
dc.identifier.citationEdvardsen, Hansen, Ueland, Aukrust, Brækkan, Morelli, Hansen. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism. Journal of Thrombosis and Haemostasis. 2023;21(5):1227-1237
dc.identifier.cristinIDFRIDAID 2158179
dc.identifier.doi10.1016/j.jtha.2023.01.024
dc.identifier.issn1538-7933
dc.identifier.issn1538-7836
dc.identifier.urihttps://hdl.handle.net/10037/32627
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalJournal of Thrombosis and Haemostasis
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.titleImpact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolismen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record